Metraipolis › archive › dc_ccc471602f6f

Research and development investments for biologics independently developed by US biotechnology startups, 2017-2023 — Europe PMC PMID:40717765

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40717765
DOI
10.1093/haschl/qxaf139
License (as archived)
solo-consultazione
Archived
2026-10-15T17:24:55.566Z
SHA-256 of the archived text
1b06af123d20e8b8f4f9ac6ac3c78fce6aff0c18ce538120680e3fa185553931
Stable URL of this page
https://metraipolis.com/documento/dc_ccc471602f6f

How to cite

Research and development investments for biologics independently developed by US biotechnology startups, 2017-2023 — Europe PMC PMID:40717765 — Europe PMC (en), https://europepmc.org/article/MED/40717765 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ccc471602f6f (Metraipolis archive dc_ccc471602f6f, sha256 1b06af123d20e8b8f4f9ac6ac3c78fce6aff0c18ce538120680e3fa185553931)
BibTeX
@misc{dcccc471602f6f,
  title = {Research and development investments for biologics independently developed by US biotechnology startups, 2017-2023 — Europe PMC PMID:40717765},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40717765},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ccc471602f6f; sha256 1b06af123d20e8b8f4f9ac6ac3c78fce6aff0c18ce538120680e3fa185553931},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40717765. Agents can read the archived copy with the MCP tool read_document.